FDA Clears the First Smart Watch for Use in Neurology

February 7, 2018

(Managed Care Magazine) – The FDA has cleared the Embrace smart watch (Empatica, Inc.) for use by patients with epilepsy. Embrace uses advanced machine learning to monitor for the most dangerous kinds of seizures, known as “grand mal” or “generalized tonic-clonic” seizures, and sends an alert to summon caregivers’ help. It also provides sleep, rest, and physical activity analysis.

Recommended Reading